Last Thursday, the Centers for Medicare and Medicaid Services (CMS) published its proposed guidance for carrying out drug price reforms included in the Inflation Reduction Act. The agency is requesting public input on the outline and timeframe for implementing the Medicare Prescription Drug Inflation Rebate Program.
The program will...
As COVID-19 cases drastically subside following the surge related to the Omicron variant, Americans are beginning to relax restrictions and anxieties related to the pandemic. However, other countries around the world are now struggling to contain Omicron surges that arrived much later and experts are warning that complacency could invite...
New COVID-19 cases are plummeting nationally, with a 63% downward trend over the last two weeks. That's great news for the nation as a whole and the U.S. Department of Health and Human Services, which is hemorrhaging funding to pay for the nation's uninsured COVID-19 patients.
The Provider Relief Fund has already paid out more than...
The Centers for Medicaid and Medicare Services' (CMS) new mandates issued on Monday is requiring states and Medicaid managed care organizations (MCOs) to make changes to their Medicaid drug utilization review program by the end of the year. The guidance includes setting prescription limits for all opioid drugs and monitoring...
